Zusammenfassung
Das Versagen des rechten Ventrikels (RV) geht mit erheblicher Morbidität und Mortalität einher, wobei die Sterblichkeitsraten im Krankenhaus auf bis zu 70–75 % geschätzt werden. Rechtsherzversagen kann nach herzchirurgischen Operationen oder in bestimmten Situationen isoliert auftreten, wie z. B. nach einem akuten Myokardinfarkt, einer Lungenembolie oder Implantation eines Linksherzunterstützungssystems sowie nach einer Herztransplantation. Die medikamentöse Therapie umfasst die Optimierung des Volumenstatus sowie die Verabreichung von Inotropika, Vasopressoren und pulmonalen Vasodilatatoren. Ausgewählte Patienten mit anhaltendem RV-Versagen können von mechanischer Kreislaufunterstützung profitieren. Zunehmend werden perkutane und chirurgische, mechanische RV-Unterstützungssysteme eingesetzt. Systeme zur isolierten RV-Unterstützung umfassen perkutane Optionen wie Mikroaxialstrompumpen und extrakorporale Zentrifugalpumpe sowie chirurgische Optionen mit einem RV-Unterstützungssystem und venoarterieller extrakorporaler Membranoxygenierung. In dieser Übersicht werden Indikationen, Patientenauswahl, Behandlungsstrategien und Ergebnisse der mechanischen Kreislaufunterstützung bei RV-Versagen diskutiert.
Abstract
Right ventricular (RV) failure is associated with significant morbidity and mortality, with in-hospital mortality rates estimated to be as high as 70–75%. The RV failure can occur after cardiac surgery or isolated in certain situations, such as acute myocardial infarction, pulmonary embolism, left ventricular assist device implantation or after heart transplantation. Drug treatment includes fine tuning of the volume status and administration of inotropic agents, vasopressors and pulmonary vasodilators. Selected patients with persistent RV failure may benefit from mechanical circulatory support. Percutaneous and surgical mechanical support systems are increasingly being used. Systems for isolated RV support include percutaneous options, such as micro-axial flow pumps and extracorporeal centrifugal flow support devices as well as surgical options with RV support devices and arteriovenous extracorporeal membrane oxygenation. This review discusses the indications, patient selection, treatment strategies and outcomes of mechanical circulatory support for RV failure.
Literatur
Abiomed (2020) FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients With Right Heart Failure. In: Today E (Hrsg) (In)
Administration USFaD (2019) UPDATE: Increased Rate of Mortality in Patients Receiving Abiomed Impella RP System—Letter to Health Care Providers
Aggarwal V, Einhorn BN, Cohen HA (2016) Current status of percutaneous right ventricular assist devices: First-in-man use of a novel dual lumen cannula. Catheter Cardiovasc Interv 88:390–396
Aghili N, Bader Y, Vest AR et al (2016) Biventricular Circulatory Support Using 2 Axial Flow Catheters for Cardiogenic Shock Without the Need for Surgical Vascular Access. Circ Cardiovasc Interv 9:
Anderson MB, Goldstein J, Milano C et al (2015) Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 34:1549–1560
Chopski SG, Murad NM, Fox CS et al (2019) Mechanical Circulatory Support of the Right Ventricle for Adult and Pediatric Patients With Heart Failure. ASAIO J 65:106–116
Coromilas EJ, Takeda K, Ando M et al (2019) Comparison of Percutaneous and Surgical Right Ventricular Assist Device Support After Durable Left Ventricular Assist Device Insertion. J Card Fail 25:105–113
De Robertis F, Birks EJ, Rogers P et al (2006) Clinical performance with the Levitronix Centrimag short-term ventricular assist device. J Heart Lung Transplant 25:181–186
DeFilippis EM, Topkara VK, Kirtane AJ et al (2022) Mechanical Circulatory Support for Right Ventricular Failure. Card Fail Rev 8:e14
Dell’italia LJ, Lembo NJ, Starling MR et al (1987) Hemodynamically important right ventricular infarction: follow-up evaluation of right ventricular systolic function at rest and during exercise with radionuclide ventriculography and respiratory gas exchange. Circulation 75:996–1003
Doll JA, Ohman EM, Patel MR et al (2016) A team-based approach to patients in cardiogenic shock. Cathet Cardio Intervent 88:424–433
Elder M, Blank N, Kaki A et al (2018) Mechanical circulatory support for acute right ventricular failure in the setting of pulmonary embolism. J Interv Cardiol 31:518–524
Ferrari MW, Schulze PC, Kretzschmar D (2020) Acute right heart failure: future perspective with the PERKAT RV pulsatile right ventricular support device. Ther Adv Cardiovasc Dis 14:1753944719895902
Guglin M, Zucker MJ, Bazan VM et al (2019) Venoarterial ECMO for Adults: JACC Scientific Expert Panel. J Am Coll Cardiol 73:698–716
Haneya A, Philipp A, Puehler T et al (2012) Temporary percutaneous right ventricular support using a centrifugal pump in patients with postoperative acute refractory right ventricular failure after left ventricular assist device implantation. Eur J Cardiothorac Surg 41:219–223
Kalogeropoulos AP, Kelkar A, Weinberger JF et al (2015) Validation of clinical scores for right ventricular failure prediction after implantation of continuous-flow left ventricular assist devices. J Heart Lung Transplant 34:1595–1603
Kapur NK, Esposito ML, Bader Y et al (2017) Mechanical Circulatory Support Devices for Acute Right Ventricular Failure. Circulation 136:314–326
Kapur NK, Jumean M, Ghuloom A et al (2015) First Successful Use of 2 Axial Flow Catheters for Percutaneous Biventricular Circulatory Support as a Bridge to a Durable Left Ventricular Assist Device. Circ Heart Fail 8:1006–1008
Kapur NK, Paruchuri V, Jagannathan A et al (2013) Mechanical circulatory support for right ventricular failure. JACC Heart Fail 1:127–134
Konstam MA, Kiernan MS, Bernstein D et al (2018) Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation 137:e578–e622
Kretzschmar D, Schulze PC, Ferrari MW (2019) Concept, Evaluation, and Future Perspectives of PERKAT(R) RV‑A Novel Right Ventricular Assist Device. J Cardiovasc Transl Res 12:150–154
Krishnamoorthy A, Devore AD, Sun JL et al (2017) The impact of a failing right heart in patients supported by intra-aortic balloon counterpulsation. Eur Heart J Acute Cardiovasc Care 6:709–718
Kuchibhotla S, Esposito ML, Breton C et al (2017) Acute Biventricular Mechanical Circulatory Support for Cardiogenic Shock. J Am Heart Assoc 6:
Lavee J, Mulzer J, Krabatsch T et al (2018) An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems. J Heart Lung Transplant 37:1399–1402
Mcgiffin D, Kure C, Mclean J et al (2021) The results of a single-center experience with HeartMate 3 in a biventricular configuration. J Heart Lung Transplant 40:193–200
Nagy CD, Jumean MF, Pham DT et al (2013) Percutaneous circulatory support for biventricular failure. Circ Cardiovasc Interv 6:e12–14
Ntalianis A, Kapelios CJ, Kanakakis J et al (2015) Prolonged intra-aortic balloon pump support in biventricular heart failure induces right ventricular reverse remodeling. Int J Cardiol 192:3–8
Oßwald A, Ruhparwar A, Schmack B (2020) TandemHeart: perkutanes rechtsventrikuläres Assist Device. In: Boeken U, Assmann A, Klotz S, Born F, Rieth A, Schmid C (Hrsg) Mechanische Unterstützung im akuten Kreislaufversagen. Springer Berlin Heidelberg, Berlin, Heidelberg, S 95–109
Pappalardo F, Scandroglio AM, Latib A (2018) Full percutaneous biventricular support with two Impella pumps: the Bi-Pella approach. ESC Heart Fail 5:368–371
Pieri M, Pappalardo F (2018) Impella RP in the Treatment of Right Ventricular Failure: What We Know and Where We Go. J Cardiothorac Vasc Anesth 32:2339–2343
Rao P, Khalpey Z, Smith R et al (2018) Venoarterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock and Cardiac Arrest. Circ Heart Fail 11:e4905
Ravichandran AK, Baran DA, Stelling K et al (2018) Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device. ASAIO J 64:570–572
Schmack B, Weymann A, Popov AF et al (2016) Concurrent Left Ventricular Assist Device (LVAD) Implantation and Percutaneous Temporary RVAD Support via CardiacAssist Protek-Duo TandemHeart to Preempt Right Heart Failure. Med Sci Monit Basic Res 22:53–57
Schrage B, Burkhoff D, Rübsamen N et al (2018) Unloading of the Left Ventricle During Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock. JACC Heart Fail 6:1035–1043
Sultan I, Kilic A, Kilic A (2018) Short-Term Circulatory and Right Ventricle Support in Cardiogenic Shock Extracorporeal Membrane Oxygenation, Tandem Heart, CentriMag, and Impella. Heart Fail Clin 14:579 (+)
Sy E, Sklar MC, Lequier L et al (2017) Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: A systematic review and meta-analysis. J Crit Care 39:87–96
Takayama H, Landes E, Truby L et al (2015) Feasibility of smaller arterial cannulas in venoarterial extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 149:1428–1433
Tran HA, Pollema TL, Enciso JS et al (2018) Durable Biventricular Support Using Right Atrial Placement of the HeartWare HVAD. Asaio J 64:323–327
Tschöpe C, Van Linthout S, Klein O et al (2019) Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts. J Cardiovasc Transl Res 12:116–123
Yoshioka D, Takayama H, Garan RA et al (2017) Contemporary outcome of unplanned right ventricular assist device for severe right heart failure after continuous-flow left ventricular assist device insertion. Interact Cardiovasc Thorac Surg 24:828–834
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
S. Aziz, O. Dewald, R. Tandler und C. Heim geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Aziz, S., Dewald, O., Tandler, R. et al. Mechanische Herz-Kreislauf-Unterstützung bei akutem Rechtsherzversagen. Z Herz- Thorax- Gefäßchir (2024). https://doi.org/10.1007/s00398-024-00641-6
Accepted:
Published:
DOI: https://doi.org/10.1007/s00398-024-00641-6
Schlüsselwörter
- Akute rechtsventrikuläre Herzinsuffizienz
- Rechtsventrikuläre Assist Devices
- Venoarterielle extrakorporale Membranoxygenierung
- Kardiogener Schock
- Impella RP